DISCORDANCE OF ACUTE MYELOID LEUKEMIA SYMPTOMS REPORTED BY US PHYSICIANS AND PATIENTS
Author(s)
Pandya BJ1, Wilson S1, Hadfield A2, Horvath LE1, Medeiros BC3, Mueller CJ1, Bailey T2, Flanders SC1, Pike J2
1Astellas Pharmaceuticals, Northbrook, IL, USA, 2Adelphi Real World, Manchester, UK, 3Stanford University, Stanford, CA, USA
OBJECTIVES: Little is known about the level of agreement between physician- and patient-reported symptoms in the acute myeloid leukemia (AML) population. The objective of this analysis was to assess the level of agreement on reported AML symptoms between treating physician and AML patients
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PCN173
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Oncology
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now